Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

CD3 and prlr bispecific antibody and its construction and application

A bispecific antibody, antibody technology, applied in the direction of antibodies, specific peptides, anti-tumor drugs, etc.

Active Publication Date: 2021-02-12
SHANGHAI JIAO TONG UNIV +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above studies imply that PRLR immunotherapy may have minimal serious side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CD3 and prlr bispecific antibody and its construction and application
  • CD3 and prlr bispecific antibody and its construction and application
  • CD3 and prlr bispecific antibody and its construction and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] 1. Construction of expression vectors for fragment A and fragment B

[0054] The antibody proteins of fragment A and fragment B bind to CD3 and PRLR extracellular regions respectively, and the amino acid sequences of CD3 and PRLR extracellular regions are shown in Table 1. The expression vectors are respectively according to the antibody A protein structure ( figure 1 ), Fragment A protein consists of two heavy chains (CD3Hc and Int C Fc and a light chain (CD3Lc). Vectors corresponding to the three chains were designed separately. CD3 antibody variable region gene heavy chain and light chain sequence, the required gene segment is synthesized by gene chemistry, and the corresponding gene segments of CD3Hc and CD3Lc protein chains are assembled by PCR amplified oligonucleotide annealing connection, through the restriction site HindIII / BamH1 and other cloning expression vectors, expression vectors can choose mammalian cell expression vectors. In order to solve the hea...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a CD3 and PRLR bispecific antibody and its construction and application; by constructing heavy chain and light chain plasmids pM-CD3Hc, pM-CD3Lc and pM-Int targeting CD3 antibody fusion protein IntC C Fc, transient co-transfection into cells, affinity purification to obtain fragment A antibody; construction of heavy and light chain plasmids pM‑PRLRIntN and pM‑PRLRLc targeting PRLR antibody fusion protein IntN, transient co-transfection of cells, affinity The fragment B antibody is obtained by purification; the fragment A and B antibodies are trans-spliced ​​in vitro to obtain the CD3 and PRLR bispecific antibody. The present invention provides a new target therapy strategy for the current HER2 and ER target therapy of breast cancer; compared with PRLR blocking antibodies, PRLR‑DbsAb has a more obvious effect of inhibiting tumors.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a CD3 and PRLR bispecific antibody and its construction and application. Background technique [0002] Binding of prolactin to PRLR leads to dimerization of the receptor and intracellular signaling. Signaling through PRLRs has been linked to various processes such as mammary gland development, lactation, reproduction and immune regulation. Locally produced prolactin, in addition to prolactin produced by the anterior pituitary, can promote tumorigenesis in the autocrine form of breast cancer. PRLR is slightly expressed in breast tissue in normal tissue, and the expression level in breast cancer tissue is 30 times higher than that in normal breast tissue. In a study of two orthotopic and highly metastatic breast cancer cell lines (mouse 4T1 and human BT-474), knockdown of PRLR in 3D culture resulted in 95% tumor initiation / apoptosis of cancer stem cells ( Yonezawa, T., e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/46C12N15/85A61K39/395A61P35/00
CPCA61K2039/505A61P35/00C07K16/2809C07K16/2869C07K16/468C07K2317/31C12N15/85
Inventor 朱建伟周跃鲜宗会芳谢跃庆江华韩雷
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com